In light of the prolonged survival of Ac-deficient mice and the amelioration of many FD manifestations upon co-ablation of Asm, we wanted to test if similar results could be achieved by pharmacological inhibition of Asm. The gene discussed is SMPD1; the disease is Fabry disease.